CACI vs RBRK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CACI exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $516.54 is significantly above the defensive Graham Number ($313.75), it trades at a substantial discount to its growth-based intrinsic value of $688.83 and analyst targets. Despite bearish short-term technicals and insider selling, the company's consistent track record of earnings beats and double-digit EPS growth support a long-term bullish outlook.
RBRK exhibits a stark divergence between fundamental health and growth potential, anchored by a weak Piotroski F-Score of 2/9. While the company demonstrates explosive revenue growth (46.3%) and impressive gross margins (80.1%), it remains unprofitable with a negative book value and a bearish insider sentiment. The stock is currently priced as a high-growth speculative asset, trading at a significant premium (Forward P/E 94.82) despite poor deterministic health scores. The outlook is balanced between strong analyst optimism and deteriorating fundamental health metrics.
Compare Another Pair
Related Comparisons
CACI vs RBRK: Head-to-Head Comparison
This page compares CACI International Inc (CACI) and Rubrik, Inc. (RBRK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.